Random mutagenesis of the human immunodeficiency virus type-1 trans-activator of transcription (HIV-1 Tat)
- PMID: 1437550
- PMCID: PMC334336
- DOI: 10.1093/nar/20.20.5311
Random mutagenesis of the human immunodeficiency virus type-1 trans-activator of transcription (HIV-1 Tat)
Abstract
A new method is described for the direct construction of randomly mutagenized genes by applying the polymerase chain reaction (PCR) to an oligonucleotide synthesized using doped nucleotide reservoirs. We have demonstrated the utility of this method by generating a library of mutant HIV-1 tat genes. Several arbitrarily selected, inactive tat clones were sequenced to evaluate the extent of the mutagenesis. Moreover, fourteen recombinants encoding varying levels of transcriptional trans-activator activity were isolated by transient transfection of sub-library pools into a HeLa cell line bearing an HIV-LTR-chloramphenicol acetyltransferase (CAT) reporter gene. Sequence data revealed a spectrum of alterations including nucleotide substitutions, insertions, and deletions, suggesting that mutations arose from both the doped DNA synthesis and the subsequent PCR 'rescue' of full-length product. Sequence comparison between inactive and active Tat clones revealed a selection pressure against amino-acid substitutions within the N-terminal domains of Tat, indicating the importance of this region to trans-activation competence. In addition, single and double missense mutations within the basic-rich, TAR RNA-binding domain were seen to be tolerated within active Tat clones.
Similar articles
-
The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA.Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6234-8. doi: 10.1073/pnas.88.14.6234. Proc Natl Acad Sci U S A. 1991. PMID: 2068104 Free PMC article.
-
Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.New Biol. 1991 Aug;3(8):759-68. New Biol. 1991. PMID: 1931822
-
Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis.Nucleic Acids Res. 1989 May 11;17(9):3551-61. doi: 10.1093/nar/17.9.3551. Nucleic Acids Res. 1989. PMID: 2542902 Free PMC article.
-
The tat gene and protein of the human immunodeficiency virus type 1.New Microbiol. 1995 Jan;18(1):87-110. New Microbiol. 1995. PMID: 7760763 Review. No abstract available.
-
RNA recognition by the human immunodeficiency virus Tat and Rev proteins.Trends Biochem Sci. 1993 Jul;18(7):255-9. doi: 10.1016/0968-0004(93)90176-n. Trends Biochem Sci. 1993. PMID: 8212135 Review.
Cited by
-
A second-site mutation that restores replication of a Tat-defective human immunodeficiency virus.J Virol. 1999 Apr;73(4):2781-9. doi: 10.1128/JVI.73.4.2781-2789.1999. J Virol. 1999. PMID: 10074125 Free PMC article.
-
Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells.J Virol. 2000 Jan;74(1):344-53. doi: 10.1128/jvi.74.1.344-353.2000. J Virol. 2000. PMID: 10590123 Free PMC article.
-
Exploring the functional robustness of an enzyme by in vitro evolution.EMBO J. 1996 Mar 15;15(6):1203-10. EMBO J. 1996. PMID: 8635452 Free PMC article.
-
Analysis of resistance to human immunodeficiency virus type 1 protease inhibitors by using matched bacterial expression and proviral infection vectors.J Virol. 1995 Sep;69(9):5431-6. doi: 10.1128/JVI.69.9.5431-5436.1995. J Virol. 1995. PMID: 7636988 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous